| 1 |
Metformin recalls: regulatory background, concerns and challenges |
|
|
| Balakrishnan Sadasivam,Zeenat Fatima,Shubham Atal |
|
| Wiener klinische Wochenschrift. 2021; |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus—Part 1 |
|
|
| Srikanth Yandrapalli,George Jolly,Adam Horblitt,Gayatri Pemmasani,Abdallah Sanaani,Wilbert S. Aronow,William H. Frishman |
|
| Cardiology in Review. 2020; 28(4): 177 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Natural Products, Traditional Uses and Pharmacological Activities of the Genus Biebersteinia (Biebersteiniaceae) |
|
|
| Benyin Zhang,Xiaona Jin,Hengxia Yin,Dejun Zhang,Huakun Zhou,Xiaofeng Zhang,Lam-Son Phan Tran |
|
| Plants. 2020; 9(5): 595 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
A review of phenformin, metformin, and imeglimin |
|
|
| Raghunandan Yendapally,Donald Sikazwe,Subin S. Kim,Sushma Ramsinghani,Rheaclare Fraser-Spears,Amy P. Witte,Brittany La-Viola |
|
| Drug Development Research. 2020; |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Predisposing factors of type 2 diabetes mellitus and the potential protective role of native plants with functional properties |
|
|
| Collise Njume,Osaana Donkor,Andrew J. McAinch |
|
| Journal of Functional Foods. 2019; 53: 115 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Anti-Diabetic Drugs: Cure or Risk Factors for Cancer? |
|
|
| Jeny Laskar,Kasturi Bhattacharjee,Mahuya Sengupta,Yashmin Choudhury |
|
| Pathology & Oncology Research. 2018; |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Metformin and Chronic Renal Disease: Proposal for a “Territorial” Therapeutic Diagnostic Path |
|
|
| Michele Giannattasio,Federica Giannattasio,Francesco Mario Gentile,Giuseppe Gernone |
|
| Giornale di Tecniche Nefrologiche e Dialitiche. 2017; 29(2): 90 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Diabetes and oral therapies |
|
|
| Mohamad S. Alhadramy |
|
| Journal of Taibah University Medical Sciences. 2016; |
|
| [Pubmed] [Google Scholar] |
|
